Requires DOH to evaluate hospital compliance with federal hospital price transparency requirements.
Summary
Assembly Bill 4944 would require the New Jersey Department of Health to monitor and evaluate whether every licensed hospital in the state complies with federal hospital price transparency rules under 45 C.F.R. Part 180. The bill directs DOH to use tools such as complaint review, outside analyses of noncompliance, and website audits to assess whether hospitals are posting required standard charges and otherwise meeting federal transparency obligations.
If DOH finds noncompliance, the bill authorizes a stepped enforcement process. The department may issue a written warning, require a corrective action plan for material violations, or impose civil monetary penalties if a hospital fails to respond or comply. The bill also requires annual public reporting to the Governor, Legislature, and on DOH’s website regarding hospital compliance and any findings or recommendations.
Impact
The bill supplements Title 26 of the Revised Statutes by creating a state-level enforcement framework for federal hospital price transparency requirements. It does not replace the federal rules; instead, it gives DOH authority to monitor compliance, determine whether violations are material, require corrective action plans, and assess daily civil penalties based on hospital size, with higher maximum penalties for larger hospitals. It also establishes notice, hearing, appeal, publication, and payment procedures, and requires the Commissioner of Health to adopt implementing regulations. Hospitals licensed in New Jersey and subject to federal price transparency rules would be directly affected, especially regarding website disclosures of standard charges.
Sentiment
The bill’s apparent policy direction is generally favorable toward transparency and consumer access to hospital pricing information. Even without recorded committee testimony or votes, the structure of the bill suggests support for stronger oversight and enforcement of existing federal requirements rather than creation of a new substantive pricing regime. The absence of recorded opposition or amendments in the provided context means there is no documented public debate here, but the bill’s enforcement-heavy approach indicates a pro-transparency, pro-accountability sentiment.
Contention
The main point of potential contention is the bill’s enforcement mechanism, particularly the authority for DOH to impose civil monetary penalties and publicly post hospital noncompliance. Hospitals may view the penalty structure, daily accrual of fines, and limited appeal rights after missing the 30-day hearing deadline as burdensome or punitive. Another likely issue is the department’s discretion to determine what constitutes a “material violation” and to rely on complaints, third-party analyses, and website audits, which could raise concerns about administrative burden, due process, and the accuracy of compliance determinations.